Douglas Miehm
Stock Analyst at RBC Capital
(0.87)
# 2,724
Out of 4,479 analysts
30
Total ratings
33.33%
Success rate
-13.25%
Average return
Main Sectors:
3 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Maintains: Sector Perform | $12 → $11 | $7.11 | +54.71% | 15 | Apr 23, 2024 | |
| BLCO Bausch + Lomb | Maintains: Outperform | $20 → $18 | $14.66 | +22.78% | 7 | Apr 22, 2024 | |
| AUPH Aurinia Pharmaceuticals | Maintains: Outperform | $13 → $8 | $5.43 | +47.33% | 8 | Feb 16, 2024 |
Bausch Health Companies
Apr 23, 2024
Maintains: Sector Perform
Price Target: $12 → $11
Current: $7.11
Upside: +54.71%
Bausch + Lomb
Apr 22, 2024
Maintains: Outperform
Price Target: $20 → $18
Current: $14.66
Upside: +22.78%
Aurinia Pharmaceuticals
Feb 16, 2024
Maintains: Outperform
Price Target: $13 → $8
Current: $5.43
Upside: +47.33%